Libtayo

(cemiplimab)
7 ML cemiplimab-rwlc 50 MG/ML Injection [Libtayo]
NO BLACK BOX WARNING

Dosage & administration

The recommended dosage of LIBTAYO is 350 mg as an intravenous infusion over 30 minutes every 3 weeks.

eficacy, safety & testing

Libtayo clinical details

Mechanism of Action
Dosing
Dose Modifications
Clinical Trial [Combination Therapy]: NSCLC
Clinical Trial [Monotherapy]: NSCLC
Efficacy - OS [Combination Therapy]: NSCLC
Efficacy - PFS [Combination Therapy]: NSCLC
Safety Profile [Combination Therapy]: NSCLC
Safety Profile - Immune-Mediated Adverse Reactions [Combination Therapy]: NSCLC
Safety Profile [Monotherapy]: NSCLC
Safety Profile - Immune-Mediated Adverse Reactions [Monotherapy]: NSCLC
Efficacy Overview [Monotherapy]: NSCLC
Efficacy - OS [Monotherapy]: NSCLC
Efficacy - PFS [Monotherapy]: NSCLC
Efficacy - Subgroup Analysis: Baseline Characteristics [Monotherapy]: NSCLC
Efficacy - Exploratory Analysis: PD-L1 Expression Levels ≥50% [Monotherapy]: NSCLC
Clinical Trial [Studies 1423 and 1540]: Advanced CSCC
Clinical Trial [Baseline Characteristics]: Advanced CSCC
Efficacy Overview: Advanced CSCC
Efficacy [ORR & DOR]: Advanced CSCC
Efficacy [Long-term Follow Up Data]: Advanced CSCC
Efficacy [Tumor Response]: Advanced CSCC
Safety Profile: Advanced CSCC
Long-Term Follow Up Safety Data: Advanced CSCC
Safety Profile [Immune-mediated Adverse Reactions]: Advanced CSCC
Clinical Trial [Baseline Characteristics]: Locally Advanced BCC
Clinical Trial: Locally Advanced BCC
Efficacy [ORR DOR & TTR]: Locally Advanced BCC
Efficacy [Long-Term Follow Up Data]: Locally Advanced BCC
Safety Profile: Locally Advanced BCC
Safety Profile [Immune-Mediated Adverse Reactions]: Locally Advanced BCC

drug label

Libtayo prescribing information

Have more Libtayo questions?

Submit MSL Request
Learn More

Need to report a Libtayo issue?

ONLINE FORM
Report adverse event
Learn More

prior authorization

Libtayo Prior authorization resources

Complete Letter of Medical Necessity

NOT PROVIDED BY BRAND
Coverage Authorization Request
Coverage Authorization Appeals
Sample Letter of Medical Exception
PA Checklist
Learn More

Benefits investigation

Libtayo Surround Enrollment Form
Libtayo Surround Enrollment Form - Spanish
Learn More

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information
Learn More

financial assistance

Libtayo Financial assistance options

Co-pay savings program

commercial only
Libtayo Surround Enrollment Form
Libtayo Surround Enrollment Form - Spanish
Enroll in Patient Savings Program
Enroll in Patient Savings Program (HCP Office)
Learn More

Bridge program

commercial only
Learn More

Foundation programs

under insured
no insurance
goverment insurance
65+
Libtayo Surround Enrollment Form
Libtayo Surround Enrollment Form - Spanish
Libtayo Surround Patient Assistance Program
Learn More

patient education

Libtayo Patient education

Getting started on Libtayo

NOT PROVIDED BY BRAND
Instructions For Use: Non-Small Cell Lung Cancer

NOT PROVIDED BY BRAND
Instructions For Use: Basal Cell Carcinoma

Patient toolkit

About Libtayo: Non-Small Cell Lung Cancer
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
How Libtayo Works: Non-Small Cell Lung Cancer
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Receiving Libtayo: Non-Small Cell Lung Cancer
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Side Effects: Non-Small Cell Lung Cancer
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources: Non-Small Cell Lung Cancer
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Caregiver Resources: Non-Small Cell Lung Cancer
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Stories: Non-Small Cell Lung Cancer
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Navigators Flashcard
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Brochure: Non-Small Cell Lung Cancer
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Biomarker Testing: Non-Small Cell Lung Cancer
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Brochure: Non-Small Cell Lung Cancer - English
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Brochure: Non-Small Cell Lung Cancer - Korean
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Brochure: Non-Small Cell Lung Cancer - Vietnamese
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Brochure: Non-Small Cell Lung Cancer - Spanish
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Brochure: Non-Small Cell Lung Cancer - Chinese
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Wallet Card - English
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Libtayo Surround Copay Program Brochure
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Libtayo Surround Overview Brochure
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Libtayo: Basal Cell Carcinoma
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
How Libtayo Works: Basal Cell Carcinoma
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Receiving Libtayo: Basal Cell Carcinoma
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Side Effects: Basal Cell Carcinoma
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link